Abiomed, Inc. to unload with Impella CP for 30 minutes before percutaneous coronary intervention. Impella CP is associated with the patients having decreased Infarct size.
Abbott Laboratories to unveil its Amplatzer “Talisman”, a PFO Occlusion System. The system is developed to close the holes in the heart preventing the risk of heart stroke. The system is very beneficial for people living with patent foramen ovale (PFO).
Author Credits: Radhika Gupta, Shivam Bhutani